During EMT in tumor cells, the expression of proteins that promote cell-cell adhesion, such as E-cadherin, is decreased, while the expression of mesenchymal markers, including vimentin, MMP-2, and MMP-9, is increased, thereby enhancing cell migration and invasion capabilities (48–50). The gene discussed is MMP9; the disease is neoplasm.